Two SunValve™ TAVI Procedures Successfully Completed in Moscow, Russia

Dr. Timur Imaev and his team at the National Medical Research Center of Cardiology, Moscow, successfully implanted two SunValve™ transcatheter aortic valves. Both procedures were completed with excellent post-procedural results.

The Milestone

Two SunValve™ transcatheter aortic valve implantation (TAVI) procedures, performed by Dr. Timur Imaev, were completed successfully at the National Medical Research Center of Cardiology in Moscow. Valve positioning and deployment were precise in both cases, and post-procedural angiography confirmed ideal valve function and stable patient recovery.

This marks another step for SunValve™ on the international clinical stage — a demonstration of Chinese structural heart innovation earning the trust of global operators.

Why TAVI Matters

Aortic stenosis is one of the most common heart valve diseases in the elderly. Traditional open-heart valve replacement is highly invasive and demands a long recovery — a heavy burden for elderly, frail, or high-risk patients. TAVI changes the picture:

• No open chest. The valve is delivered via catheter and deployed at the diseased site.
• Minimally invasive. No cardiopulmonary bypass; only a small access incision.
• Fast recovery. Most patients are discharged within days after the procedure.

SunValve™ in Real-World Cases

The two implantations in Moscow put SunValve™ to the test in an international clinical setting:

• Precise deployment — stable positioning and controlled release.
• Excellent immediate results — no significant regurgitation on post-procedural imaging.
• Seamless collaboration — cross-border teamwork across imaging, planning and support.